Drug Shortage Report for AURO-LOSARTAN HCT
Report ID | 242963 |
Drug Identification Number | 02423642 |
Brand name | AURO-LOSARTAN HCT |
Common or Proper name | Auro-Losartan HCT |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-11-14 |
Estimated end date | 2025-02-14 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2025-02-06 | French | Compare |
v6 | 2025-02-06 | English | Compare |
v5 | 2025-02-03 | French | Compare |
v4 | 2025-02-03 | English | Compare |
v3 | 2024-11-15 | English | Compare |
v2 | 2024-11-14 | French | Compare |
v1 | 2024-11-14 | English | Compare |
Showing 1 to 7 of 7